Graham Number Checker

Date Checked2025-12-21 23:24:10
Graham Number(PB)55.88 vs (PE)32.86
Over / Under Value Percentage-6.42% vs 34.77%
Dividend Yield3.63%
Dividend Date2025-08-26
SymbolNVO
AssetTypeCommon Stock
NameNovo Nordisk A/S
DescriptionNovo Nordisk A/S (NVO) is a premier global healthcare company headquartered in Bagsvaerd, Denmark, renowned for its expertise in diabetes care, obesity treatment, and hormone replacement therapies. The company stands at the forefront of innovation, utilizing advanced biotechnology and rigorous scientific research to develop and manufacture high-quality pharmaceutical products aimed at chronic disease management. As a leader in the biopharmaceutical sector, Novo Nordisk is dedicated to enhancing patient outcomes and promoting sustainability, while upholding a strong commitment to ethical business practices and corporate responsibility.
CIK353278
ExchangeNYSE
CurrencyUSD
CountryUSA
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
AddressNOVO ALLE 1, BAGSVAERD, DENMARK, 2880
OfficialSitehttps://www.novonordisk.com
FiscalYearEndDecember
LatestQuarter2025-09-30
MarketCapitalization213242593000
EBITDA165492998000
PERatio13.22
PEGRatio1.62
BookValue38.23
DividendPerShare11.65
EPS3.63
RevenuePerShareTTM71.0
ProfitMargin0.329
OperatingMarginTTM0.444
ReturnOnAssetsTTM0.211
ReturnOnEquityTTM0.715
RevenueTTM315602993000
GrossProfitTTM263334003000
DilutedEPSTTM3.63
QuarterlyEarningsGrowthYOY-0.265
QuarterlyRevenueGrowthYOY0.051
AnalystTargetPrice53.25
AnalystRatingStrongBuy1
AnalystRatingBuy6
AnalystRatingHold3
AnalystRatingSell2
AnalystRatingStrongSell0
TrailingPE13.22
ForwardPE12.12
PriceToSalesRatioTTM0.676
PriceToBookRatio8.04
EVToRevenue4.495
EVToEBITDA9.4
Beta0.352
52WeekHigh109.5
52WeekLow43.08
50DayMovingAverage52.29
200DayMovingAverage63.28
SharesOutstanding3368607000
SharesFloat3187974000
PercentInsiders0.004
PercentInstitutions9.118
ExDividendDate2025-08-18
dateChecked2025-12-21 23:24:10
fresh1